COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review

Coronavirus disease 2019 (COVID-19) pandemic has affected more than 40 million people worldwide. Some patients had episodes of symptom recurrence after the first episode of infection with variable intervals. There are multiple issues and hypotheses about re-infection or re-activation of the virus, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tehrani, H.A., Darnahal, M., Nadji, S.A., Haghighi, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777517/
https://www.ncbi.nlm.nih.gov/pubmed/33425365
http://dx.doi.org/10.1016/j.nmni.2020.100830
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) pandemic has affected more than 40 million people worldwide. Some patients had episodes of symptom recurrence after the first episode of infection with variable intervals. There are multiple issues and hypotheses about re-infection or re-activation of the virus, especially in immunocompromised patients. In this paper, we present details of an individual with a recent history of COVID-19 who proceeded to acute myeloid leukaemia M3 and immunosuppression by chemotherapy, then we review some recently published articles about possible re-infection or re-activation.

Ejemplares similares